NCT00346294View on ClinicalTrials.gov

An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2006

Study Completion Date

July 31, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etanercept

Intervention type was to study the drug delivery method.

Sponsors

Lead Sponsor

Amgen

Collaborators (1)

Immunex Corporation
All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

lead

Amgen

INDUSTRY